Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/0002-9149(86)90878-7 http://scihub22266oqcxt.onion/10.1016/0002-9149(86)90878-7 3524185!ä!3524185 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\3524185.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Am+J+Cardiol 1986 ; 58 (2): 18A-21A Nephropedia Template TP {{tp|p=3524185|t=1986. Hypokalemia in thiazide-treated systemic hypertension |pdf=|usr=}}{{3524185}} gab.com Text Hypokalemia in thiazide-treated systemic hypertension JO: Am J Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=3524185 #FOAvip Potassium supplementation in diuretic-induced hypokalemia (serum potassium less than 3.5 mmol/liter) in patients being treated for hypertension is a common event. In a previous study 40 mmol/day of orally administered potassium was not effective in preventing diuretic-induced hypokalemia in patients who had previously developed hypokalemia while being treated for hypertension with hydrochlorothiazide. In the study reported here dosages as high as 60 to 80 mmol/day of orally administered potassium failed to prevent hypokalemia in 7 of 19 hypertensive patients who were receiving hydrochlorothiazide. Potassium supplementation was compared with the potassium-sparing diuretic amiloride. The study design was open label and subject matched with crossover of therapeutic regimens. Twit Text FOAVip Hypokalemia in thiazide-treated systemic hypertension ????Am J Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=3524185 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=3524185 #FOAvip English Wikipedia <ref>{{Cite pmid|3524185}}</ref> Hypokalemia in thiazide-treated systemic hypertension #MMPMID3524185 Maronde RF; Chan LS; Vlachakis N Am J Cardiol 1986[Jul]; 58 (2): 18A-21A PMID3524185show ga Potassium supplementation in diuretic-induced hypokalemia (serum potassium less than 3.5 mmol/liter) in patients being treated for hypertension is a common event. In a previous study 40 mmol/day of orally administered potassium was not effective in preventing diuretic-induced hypokalemia in patients who had previously developed hypokalemia while being treated for hypertension with hydrochlorothiazide. In the study reported here dosages as high as 60 to 80 mmol/day of orally administered potassium failed to prevent hypokalemia in 7 of 19 hypertensive patients who were receiving hydrochlorothiazide. Potassium supplementation was compared with the potassium-sparing diuretic amiloride. The study design was open label and subject matched with crossover of therapeutic regimens. |Aldosterone/blood[MESH] |Amiloride/therapeutic use[MESH] |Clinical Trials as Topic[MESH] |Drug Therapy, Combination[MESH] |Humans[MESH] |Hydrochlorothiazide/administration & dosage/*adverse effects/therapeutic use[MESH] |Hypertension/*drug therapy[MESH] |Hypokalemia/*chemically induced[MESH] |Magnesium/blood[MESH] |Potassium Chloride/administration & dosage/therapeutic use[MESH] |Potassium/blood[MESH] |Random Allocation[MESH]Hypokalemia in thiazide-treated systemic hypertension (epmc).pdf DeepDyve Pubget Overpricing